Seborrheic keratosis is a condition that causes wart-like growths on the skin. The growths are noncancerous (benign).
Benign skin tumors - keratosis; Keratosis - seborrheic; Senile keratosis; Senile verruca
A seborrheic keratosis is a benign form of skin tumor. The cause is unknown.
The condition commonly appears after age 40. It tends to run in families.
Symptoms of seborrheic keratosis are skin growths that:
You generally do not need treatment unless growths get irritated or affect your appearance.
Growths may be removed with surgery or freezing (cryotherapy).
Jie Liu practices in Beijing, China. Liu is rated as an Elite expert by MediFind in the treatment of Seborrheic Keratosis. They are also highly rated in 204 other conditions, according to our data. Their top areas of expertise are Seborrheic Keratosis, Necrosis, Cerebral Hypoxia, Endoscopy, and Oophorectomy.
Caterina Longo practices in Reggio Nell'emilia, Italy. Longo is rated as an Elite expert by MediFind in the treatment of Seborrheic Keratosis. She is also highly rated in 29 other conditions, according to our data. Her top areas of expertise are Basal Cell Skin Cancer, Melanoma, Seborrheic Keratosis, Actinic Keratosis, and Bone Marrow Transplant.
Kimberly Grande is a Dermatologist in Knoxville, Tennessee. Grande has been practicing medicine for over 29 years and is rated as an Elite expert by MediFind in the treatment of Seborrheic Keratosis. She is also highly rated in 3 other conditions, according to our data. Her top areas of expertise are Seborrheic Keratosis, Rosacea, Warts, and Actinic Keratosis. She is licensed to treat patients in Tennessee. Grande is currently accepting new patients.
Removing the growths is simple and generally does not cause scars. You may have patches of lighter skin where growths on the torso have been removed.
Growths usually do not return after they are removed. You may develop more growths in the future if you are prone to the condition.
These complications may occur:
Call your provider if you have symptoms of seborrheic keratosis.
Also call if you have new symptoms, such as:
Summary: This is a first-in-humans adaptive design open label trial to explore the safety and efficacy of SM-020. Multiple dosing cohorts will be enrolled. The first cohort will have a two-week treatment period of twice daily applications followed by a four-week follow-up period. Based on the results at any time from the first and subsequent cohorts, additional cohorts will explore different dosing regimen...
Published Date: November 10, 2020
Published By: Ramin Fathi, MD, FAAD, Director, Phoenix Surgical Dermatology Group, Phoenix, AZ. Also reviewed by David Zieve, MD, MHA, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.
Fitzpatrick JE, High WA, Kyle WL. Papillomatous and verrucous lesions. In: Fitzpatrick JE, High WA, Kyle WL, eds. Urgent Care Dermatology: Symptom-Based Diagnosis. Philadelphia, PA: Elsevier; 2018:chap 28.
James WD, Elston DM, Treat JR, Rosenbach MA, Neuhaus IM. Epidermal nevi, neoplasms, and cysts. In: James WD, Elston DM, Treat JR, Rosenbach MA, Neuhaus IM, eds. Andrews' Diseases of the Skin: Clinical Dermatology. 13th ed. Philadelphia, PA: Elsevier; 2020:chap 29.
Marks JG, Miller JJ. Epidermal growths. In: Marks JG, Miller JJ, eds. Lookingbill and Marks' Principles of Dermatology. 6th ed. Philadelphia, PA: Elsevier; 2019:chap 5.
Requena L, Requena C, Cockerell CJ. Benign epidermal tumors and proliferations. In: Bolognia JL, Schaffer JV, Cerroni L, eds. Dermatology. 4th ed. Philadelphia, PA: Elsevier; 2018:chap 109.